Not Signed In - Mylan Announces Final Approval For Additional Strengths Of Estradiol Transdermal Systems
Wed, 26 Jul 2006 06:00 AM EST
... Mylan Laboratories Inc.(NYSE: MYL) today announced that the U.S. Food and Drug Administration hasgranted final approval for Mylan Technologies Inc.'s (MTI) supplementalAbbreviated New Drug Application for Estradiol Transdermal Systems, 0.0375mg/day and 0.06 mg/day. [click link for full article] ...
Related Topics
- Estradiol
- Estradiol and Norethindrone Transdermal Patch
- Estradiol Transdermal System
- Testosterone Transdermal
- Ethinyl Estradiol and Norelgestromin Transdermal System
- Estradiol and Levonorgestrel
- Vaccine Testing & Approval
- Estradiol Injection
- Estradiol and Norgestimate
- Failure of body systems
- Estradiol Vaginal Tablets
- Fentanyl Skin Patches
- Estradiol-containing Medications
- Ethinyl Estradiol
- Estradiol and Norethindrone
- Mammograms
- Tarceva
- Nicotine Skin Patches
- Alternative medical systems
- Estradiol Vaginal Ring
email this page
print this page
bookmark this page
feedback on this page
